The Valley Desk

NCT01265199 · Interventional trial

Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Properties of Oral AT-406 in Combination With Daunorubicin and Cytarabine in Patients With Poor-risk Acute Myelogenous Leukemia (AML)

Overall registry status Terminated

Phase 1

Conditions Acute Myelogenous Leukemia (AML)

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov